Inventor · Doylestown, PA, US

Timothy M. Block

36Patents
9h-index
40Co-inventors
75Inventor score

Filing activity: Oct 6, 1993 → Apr 20, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US8097728B2 Iminosugar compounds with antiflavirus activity Human Necessities 40 Active
US8609668B2 Substituted triazolo[1,5-A]pyrimidines as antiviral agents Human Necessities 39 Active
US9623071B2 Modulation of hepatitis B virus CCCDNA transcription Chemistry; Metallurgy 27 Active
US6689759B1 Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy Human Necessities 18 Expired
US6465487B1 Inhibition of membrane-associated viral replication Emerging Cross-Sectional Technologies 14 Expired
US9399619B2 Sulfamoylbenzamide derivatives as antiviral agents against HBV infection Human Necessities 12 Active
US7816560B1 Long chain n-alkyl compounds and oxa-derivatives thereof Emerging Cross-Sectional Technologies 10 Expired
US7776550B2 Diagnosis of liver pathology through assessment of protein glycosylation Physics 10 Expired
US9089515B2 Long chain N-alkyl compounds and oxa-derivatives thereof Emerging Cross-Sectional Technologies 9 Active
US6809083B1 Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections Human Necessities 9 Expired
US8183000B2 Diagnosis of liver pathology through assesment of protein glycosylation Physics 6 Active
US9642830B2 Use of sting agonists to treat hepatitis B virus infection Physics 5 Active
US5532124A Genetically engineered bacteria to identify and produce medically important agents Emerging Cross-Sectional Technologies 4 Expired
US10045961B2 Use of sting agonists to treat chronic hepatitis B virus infection Physics 3 Active
US6037351A Method of inhibiting hepatitis B virus Human Necessities 2 Expired
US7612093B2 Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy Human Necessities 2 Active
US8921381B2 Inhibitors of secretion of hepatitis B virus antigens Human Necessities 1 Active
US6355248B1 Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent Emerging Cross-Sectional Technologies 1 Expired
US9110078B2 Diagnosis of liver pathology through assessment of anti-gal IgG glycosylation Physics 1 Active
US10143720B2 Modulation of hepatitis B virus cccDNA transcription Chemistry; Metallurgy 0 Active
US10421723B2 2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of use Chemistry; Metallurgy 0 Active
US10180436B2 Diagnosis of liver pathology through assessment of anti-gal IgG glycosylation Physics 0 Active
US9126937B2 Alkylated imino sugars exhibiting glucosidase inhibition and their method of use Chemistry; Metallurgy 0 Active
US9657013B2 Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use Chemistry; Metallurgy 0 Active
US8193328B2 Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.